KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Change in Acquisitions & Divestments (2018 - 2025)

Adaptive Biotechnologies' Change in Acquisitions & Divestments history spans 8 years, with the latest figure at $39.1 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 41.62% year-over-year to $39.1 million; the TTM value through Dec 2025 reached $222.6 million, down 31.65%, while the annual FY2025 figure was $222.6 million, 31.65% down from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $39.1 million at Adaptive Biotechnologies, down from $50.9 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $155.0 million in Q4 2021 and bottomed at $35.0 million in Q2 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $95.8 million (2022), against an average of $98.8 million.
  • The largest annual shift saw Change in Acquisitions & Divestments tumbled 75.78% in 2022 before it skyrocketed 301.15% in 2023.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $155.0 million in 2021, then crashed by 54.82% to $70.0 million in 2022, then skyrocketed by 80.63% to $126.5 million in 2023, then crashed by 47.04% to $67.0 million in 2024, then plummeted by 41.62% to $39.1 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Change in Acquisitions & Divestments are $39.1 million (Q4 2025), $50.9 million (Q3 2025), and $55.1 million (Q2 2025).